Sophia Genetics in deal with Britain's NHS, and a leading Turkish lab

Sophia Genetics, a European leader in data driven medicine, has significantly expanded its European customer base through its first deal with the National Health Service in the UK, and an agreement with a leading (unnamed) Turkish laboratory.

This follows a surge in demand for the company's clinical genomics offerings among laboratories and hospitals in Germany, France and Italy, with additional customer relationships in these countries established in August, the company stated.

These customers now gain access to Sophia Genetics' innovative data driven medicine platform, which offers securely-hosted software as a service module covering the bioinformatics analysis protocol, the validation and quality control process, the presentation of results of genetic tests to clinicians and the protection of patient DNA sequence data through safe storage and sharing.